An investigation on behalf of investors in Intermolecular Inc (NASDAQ:IMI) shares over potential wrongdoing at Intermolecular was announced NASDAQ:IMI stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 05/13/2016 --An investigation on behalf of current long-term investors in shares of Intermolecular Inc (NASDAQ:IMI) was announced over potential breaches of fiduciary duties by certain officers and directors at Intermolecular Inc.

Investors who purchased shares of Intermolecular Inc (NASDAQ:IMI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm concerns whether certain Intermolecular officers and directors breached their fiduciary duties.

Intermolecular Inc reported that its annual Total Revenue declined from $47.70 million in 2014 to $45.32 million in 2015 and that its Net Loss declined from $21.76 million in 2014 to $21.01 million in 2015.

Shares of Intermolecular Inc (NASDAQ:IMI) declined from $10.39 per share in March 2013 to as low as $1.61 per share in March 2015.

On May 11, 2016, NASDAQ:IMI shares closed at $2.00 per share.

Those who purchased shares of Intermolecular Inc have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com